| 中文别名 |
博赛泼维;波普瑞韦;(1R,2S,5S)-N-(4-氨基-1-环丁基-3,4-二氧代-2-丁基)-3-((S)-2-(3-(叔丁基)脲啶)-3,3-二甲基丁酰基)-6,6-二甲基-3-氮杂双环[3.1.0]己烷-2-羧酰胺;(1R,2S,5S)-N-(4-氨基-1-环丁基-3,4-二氧代丁烷-2-基)-3-[(2S)-2-(叔丁基氨基甲酰氨基)-3,3-二甲基丁酰基]-6,6-二甲基-3-氮杂双环[3.1.0]己烷-2-甲酰胺;波普瑞伟;波西匹韦;波西普韦标准品;伯克匹韦;伯克匹韦、维拉佐酮杂质及标准品;博普瑞韦;博塞匹韦;博赛匹韦;用boceprevir |
| 英文别名 |
boceprevir;[14C]-Boceprevir;BOCEPRAVIR;BOCEPREVIR EBP520 SCH503034;Boceprevir metabolites SCH 534128;Boceprevir SCH 534129 (Inactive metabolite);EBP 520;EBP-520;SCH 503034;SCH-503034;(1R,2S,5S)-N-(4-Amino-1-cyclobutyl-3,4-dioxobutan-2-yl)-3-[(2S)-2-(tert-butylcarbamoylamino)-3,3-dimethylbutanoyl]-6,6-dimethyl-3-azabicyclo[3.1.0]hexane-2-carboxamide;3-{[(1R,2S,5S)-3-[(2S)-2-[(tert-butylcarbamoyl)amino]-3,3-dimethylbutanoyl]-6,6-dimethyl-3-azabicyclo[3.1.0]hexan-2-yl]formamido}-4-cyclobutyl-2-oxobutanamide;EBP520;(1R,2S,5S)-N-(3-Amino-1-(cyclobutylmethyl)-2,3-dioxopropyl)-3-((2S)-2-((((1,1-dimethylethyl)amino)carbonyl)amino)-3,3-dimethyl-1-oxobutyl)-6,6-dimethyl-3-azabicyclo(3.1.0)hexane-2-carboxamide;BOCEPREVIR [INN];HY-10237;(1R,2S,5S)-N-(4-amino-1-cyclobutyl-3,4-dioxobutan-2-yl)-3-[N-(tert-butylcarbamoyl)-3-methyl-L-valyl]-6,6-dimethyl-3-azabicyclo[3.1.0]hexane-2-carboxamide;J-519910;s3733;Victrelis;DT-0021;Boceprevir (INN/USAN);3-azabicyclo[3.1.0]hexane-2-carboxamide, N-[3-amino-1-(cyclobutylmethyl)-2,3-dioxopropyl]-3-[(2S)-2-[[[(1,1-dimethylethyl)amino]carbonyl]amino]-3,3-dimethyl-1-oxobutyl]-6,6-dimethyl-, (1R,2S,5S)-;BDBM12311;Boceprevir [USAN];BOC;AKOS005145787;HSDB 8081;Boceprevir;SCHEMBL640836;DB08873;Q410551;BRD-A09735281-001-03-3;BOCEPREVIR [WHO-DD];89BT58KELH;DTXSID30960103;CCG-269852;(1R,2S,5S)-N-(4-amino-1-cyclobutyl-3,4-dioxobutan-2-yl)-3-(N-(tert-butylcarbamoyl)-3-methyl-L-valyl)-6,6-dimethyl-3-azabicyclo(3.1.0)hexane-2-carboxamide;BOCEPREVIR [VANDF];MFCD22208555;NCGC00378631-01;(1R,2S,5S)-N-(3-Amino-1-(cyclobutylmethyl)-2,3-dioxopropyl)-3-((2S)-2-(((1,1-dimethylethyl)carbamoyl)amino)-3,3-dimethylbutanoyl)-6,6-dimethyl-3-azabicyclo(3.1.0)hexane-2-carboxamide;BOCEPREVIR [ORANGE BOOK];BOCEPREVIR (MART.);BCP02502;Boceprevir(EBP 520; SCH 503034 )?;N-(4-Amino-1-cyclobutyl-3,4-dioxobutan-2-yl)-3-{N-[(tert-butylamino)(hydroxy)methylidene]-3-methylvalyl}-6,6-dimethyl-3-azabicyclo[3.1.0]hexane-2-carboximidic acid;Boceprevir & NM107;Boceprevir [USAN:INN];EN300-7410986;CHEMBL218394;BOCEPREVIR [MI];EX-A1336;EBP-520;SCH503034;SCH503034;DA-61803;UNII-89BT58KELH;CHEBI:68621;BOCEPREVIR [EMA EPAR];3-AZABICYCLO(3.1.0)HEXANE-2-CARBOXAMIDE, N-(3-AMINO-1-(CYCLOBUTYLMETHYL)-2,3-DIOXOPROPYL)-3-((2S)-2-((((1,1-DIMETHYLETHYL)AMINO)CARBONYL)AMINO)-3,3-DIMETHYL-1-OXOBUTYL)-6,6-DIMETHYL-, (1R,2S,5S)-;J05AP03;394730-60-0;SCH 503034 & NM107;(1R,2S,5S)-N-(4-AMINO-1-CYCLOBUTYL-3,4-DIOXOBUTAN-2-YL)-3-[(2S)-2-(TERT-BUTYLCARBAMOYLAMINO)-3,3-DIMETHYLBUTANOYL]-6,6-DIMETHYL-3-AZABICYCLO[3.1.0]HEXANE-2-CARBOXAMIDE;D08876;GTPL7876;Victrelis(TM);boceprevirum;Victrelis (TN);BRD-A09735281-001-02-5;(1R,2S,5S)-N-[3-Amino-1-(cyclobutylmethyl)-2,3-dioxopropyl]-3-[(2S)-2-[[(1,1-dimethylethyl)carbamoyl]amino]-3,3-dimethylbutanoyl]-6,6-dimethyl-3-azabicyclo[3.1.0]hexane-2-carboxamide;(1r,5s)-n-[3-amino-1-(cyclobutylmethyl)-2,3-dioxopropyl]-3-[2(s)-[[[(1,1-dimethy... |